HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

485.138

-11.620-2.34%

Number of Gainers:7

Number of Losers:24

Number of Flat:2

PE:- -

High:496.758

Open:496.758

Low:480.418

Close:496.758

Volume:65.25M

Turnover:1.54B

Market Cap:307.80B

Float Cap:274.48B

Loading ...

Ocumension Says China Regulator Accepts Domestic Filing for Dexamethasone Eye Injection OT-502

Ocumension Therapeutics - Acceptance of Application for Drug Registration of Domestically Produced Dexamethasone Intraocular Suspension

THOMSON REUTERS

Fund Manager Trims Stake in KEYMED BIO-B With HK$3.76M Share Sale

Executive Director Wang Yuxiao Reduces Stake in Remegen with Share Sale

Zylox-Tonbridge Files HKEX Next-Day Disclosure Return Reporting Share Repurchase for Cancellation

Tellgen Corporation Secures Six New Medical Device Approvals

Medical Sector Hitting an Earnings Inflection Point? 512170 Ends Green Amid AI4S Boost for HK CXO Stocks

AH Share Premium Rankings for September 1st

Shandong Oriental Ocean Secures Regulatory Approval for Its Scavenger Receptor-A Assay Kit

Novartis Faces Dual Outcomes: CAR-T Halted After Three Deaths While MS Drug Shows Late-Stage Promise

Edding Genor Chairman to Boost Shareholding

MT Newswires Live

Pharmaceutical Agent Sentenced for Bribery After Profiting 1.47 Million and Returning 1.5 Million

MP CARDIOFLOW-B (02160) Trading Halt Scheduled From September 1st

Dizal's Sunvozertinib Licensing Deal with AstraZeneca Officially Takes Effect

Trump Administration’s Medicaid Drug Pricing Deal Set to Stir Asian Pharma Stocks

EDDING GENOR (06998) Spends HK$619,900 on Share Buyback on August 31

CanSino Biologics Inc. Just Missed Earnings - But Analysts Have Updated Their Models

Simply Wall St.

Sweden's Klaria Net Loss Narrows on Lower R&D Expenses

Edding Genor Files HKEX Next-Day Disclosure Return on Share Buyback at HKD 1.56 Avg Price

Sinomab Bioscience Posts HY Loss of Rmb127.4 Million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/BK1574/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":485.13806,"timestamp":1789104837310,"preClose":496.75812,"halted":0,"volume":65253161,"delay":0,"changeRate":-0.023392,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-11.620056,"latestTime":"09-11 13:33:59","open":496.75812,"high":496.75812,"low":480.41833,"amount":1543366895,"amplitude":0.032893,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789114200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"pbRate":3.703217,"peRate":164.740195,"turnoverRate":0.002483,"increases":7,"decrements":24,"flats":1,"marketCap":307798848880,"floatMarketCap":274475576072},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":496.75812,"amplitude":0.032893,"preClose":496.75812,"low":480.41833,"pbRate":"3.703217","latestPrice":485.13806,"volume":65253161,"delay":0,"open":496.75812,"prevYearClose":556.26263,"prevWeekClose":532.025,"prevMonthClose":503.398,"prevQuarterClose":453.519,"fiveDayClose":532.025,"twentyDayClose":518.327,"sixtyDayClose":434.471,"secType":"PLATE","market":"HK","turnoverRate":0.002483,"peRate":164.740195,"marketCap":307798848880,"floatMarketCap":274475576072,"timestamp":1789104837310,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":7,"down":24,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664656856","title":"Ocumension Says China Regulator Accepts Domestic Filing for Dexamethasone Eye Injection OT-502","url":"https://stock-news.laohu8.com/highlight/detail?id=2664656856","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664656856?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:58","pubTimestamp":1788263913,"startTime":"0","endTime":"0","summary":"Ocumension says China regulator accepts domestic filing for dexamethasone eye injection OT-502Ocumension Therapeutics received NMPA CDE acceptance for a domestic registration filing for dexamethasone ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL68RHHj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1574","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664566538","title":"Ocumension Therapeutics - Acceptance of Application for Drug Registration of Domestically Produced Dexamethasone Intraocular Suspension","url":"https://stock-news.laohu8.com/highlight/detail?id=2664566538","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664566538?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:58","pubTimestamp":1788263908,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44T0HG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01477","BK1574","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141085303","title":"Fund Manager Trims Stake in KEYMED BIO-B With HK$3.76M Share Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=1141085303","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141085303?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:50","pubTimestamp":1788263416,"startTime":"0","endTime":"0","summary":"Hong Kong stock exchange filings reveal that on August 27, China Universal Asset Management Co., Ltd. reduced its holdings in KEYMED BIO-B (02162) by 48,000 shares.The shares were sold at an average...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1583","02162","BK1161","BK1587","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119974337","title":"Executive Director Wang Yuxiao Reduces Stake in Remegen with Share Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=1119974337","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119974337?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:44","pubTimestamp":1788263056,"startTime":"0","endTime":"0","summary":"Hong Kong Exchange records show that on August 26, Executive Director Wang Yuxiao sold 6,500 shares of Remegen (09995) at an average price of HK$82 per share, totaling HK$533,000.Following the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","LU2148510915.USD","EWH","LU1969619763.USD","LU2488822045.USD","BK0239","688331","LU1064130708.USD","09995","LU1064131003.USD","BK1583","LU2328871848.SGD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664557078","title":"Zylox-Tonbridge Files HKEX Next-Day Disclosure Return Reporting Share Repurchase for Cancellation","url":"https://stock-news.laohu8.com/highlight/detail?id=2664557078","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664557078?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:43","pubTimestamp":1788262982,"startTime":"0","endTime":"0","summary":"Zylox-Tonbridge files HKEX next-day disclosure return reporting share repurchase for cancellationZylox-Tonbridge repurchased 53,000 H shares on Sept. 1, 2026 for treasury.Buyback executed on HKEX at H","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL1Xjkz2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190","BK1574","BK1100","BK1583","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157462487","title":"Tellgen Corporation Secures Six New Medical Device Approvals","url":"https://stock-news.laohu8.com/highlight/detail?id=1157462487","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157462487?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:36","pubTimestamp":1788262589,"startTime":"0","endTime":"0","summary":"Tellgen Corporation (300642.SZ) has announced that the company and its controlling subsidiary, Shanghai Maishi Biotechnology Co., Ltd., recently obtained six medical device registration certificates...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK1574","AGNG","MEDX","BK0046","09996","159883","BK0042","LNGR","IEIH","BK1100","PTH","BK1583","300642","MDEV","GDOC","HART","RSPH","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141380242","title":"Medical Sector Hitting an Earnings Inflection Point? 512170 Ends Green Amid AI4S Boost for HK CXO Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1141380242","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141380242?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:20","pubTimestamp":1788261656,"startTime":"0","endTime":"0","summary":"On September 1st, medical stocks in both A-shares and Hong Kong markets bucked the market's downbeat trend, with related products such as Medical ETF Huabao (512170) and HK Stock Connect Medical ETF...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","VXUS","RSPH","LNGR","CXO","09996","HART","159883","GDOC","KCAI","BK1583","MDEV","AGNG","FLHK","BK4585","BK1574","BK1100","LGHT","BK4588","MEDX","IEIH","512170","WX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113792305","title":"AH Share Premium Rankings for September 1st","url":"https://stock-news.laohu8.com/highlight/detail?id=1113792305","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113792305?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:24","pubTimestamp":1788251095,"startTime":"0","endTime":"0","summary":"According to market data as of the close on September 1st, NE Electric Co Ltd (00042) (HKD 0.235/A-share RMB 2.25), ZHEJIANG SHIBAO Co Ltd (01057) (HKD 4.215/A-share RMB 18.24), and HOLLY FUTURES Co...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03678","LU0314109678.HKD","LU0228659784.USD","LU0164865239.USD","LU0164880469.USD","LU2294711473.HKD","LU0072913022.USD","SG9999004220.SGD","LU1152091168.USD","BK1576","LU1719994722.HKD","LU0181495838.USD","LU2476274308.USD","LU1255011170.USD","LU1769817179.HKD","IE00BZ08YS42.EUR","LU2399975544.HKD","LU1251922891.USD","03750","LU0821914370.USD","SG9999011746.SGD","02846","BK1515","LU0164939612.USD","LU1188198961.HKD","LU0315179316.USD","SG9999001093.SGD","LU1831875114.USD","BK1183","LU0106959298.USD","LU0791591158.USD","LU0266512473.USD","LU0348766576.USD","LU1769817096.USD","LU0862451753.SGD","LU0173614495.USD","LU0640798160.USD","LU1282649810.SGD","LU0043850808.USD","LU0149721374.USD","BK1190","LU0254981946.USD","LU1808992512.USD","03968","LU0052750758.USD","LU0211977185.USD","HK0001040143.USD","02865","BK1522","BK1505","BK1583","BK1544","BK1144","LU0117841782.USD","03143","BK1214","BK1610","BK1170","LU1481107354.HKD","IE00BVYPNQ40.USD","LU2097828557.USD","02701","LU1807302812.USD","BK1231","LU0516423091.SGD","BK1147","LU0359202008.SGD","LU0737861699.HKD","HK0000320223.HKD","IE00BVYPNP33.GBP","02218","BK1551","LU2476274720.SGD","BK1161","LU0244354667.USD","LU0359201612.USD","LU0228367735.SGD","LU0348827113.USD","LU2778985437.USD","LU1655091616.SGD","07233","LU0307460666.USD","LU0540923850.HKD","01349","LU1770034418.SGD","LU1282648689.USD","LU0320764755.SGD","IE00B3M56506.USD","LU0516422366.SGD","BK1593","LU0543330483.HKD","LU2008162690.USD","BK1592","LU0348805143.USD","HK0001040168.HKD","LU0348788117.USD","159982","IE0034224299.USD","LU1211504680.USD","06066","LU0456827905.SGD","LU0634319403.HKD","LU0918141887.USD","BK1237","BK1249","06185","LU0096374516.USD","LU0488056044.USD","LU1064131342.USD","IE0031814852.USD","LU1675838814.USD","LU0672654166.SGD","IE00BZ08YT58.USD","LU1813983027.USD","03188","LU0449509016.USD","IE00B29SXG58.USD","LU1688375341.USD","LU0431992006.USD","IE0008368742.USD","SG9999002463.SGD","LU0326950275.SGD","IE00BZ08YR35.GBP","LU0231483743.USD","SG9999001226.SGD","LU0082770016.USD","LU0345780281.USD","02691","IE00BF5LJ272.USD","IE00B543WZ88.USD","LU0328353924.USD","LU0348825331.USD","IE00B5MMRT66.SGD","LU0469268626.HKD","00042","LU0823426308.USD","LU0516423174.USD","LU0868486357.SGD","LU2125910500.SGD","LU1880383440.USD","LU0918141705.HKD","00187","BK1198","BK1122","LU0737861772.HKD","LU1328277881.USD","LU0797268264.HKD","02475","LU0128522157.USD","LU0417516738.SGD","IE00B031HY20.USD","LU0348814723.USD","LU1303224171.USD","BK1171","BK1574","LU2045819591.USD","BK1523","LU0320764599.SGD","EWH","LU0890818403.SGD","LU0229945570.USD","BK1105","LU0456854461.SGD","LU0329678337.USD","06821","BK1554","BK1163","BK1514","LU0880133367.SGD","82846","BK1562","06869","LU1720050803.USD","SG9999006597.SGD","LU0149534421.HKD","01877","LU0269904917.USD","LU2039709279.SGD","LU0509642566.USD","LU0543330566.HKD","LU1152091754.HKD","LU2097828714.EUR","LU0823426480.USD","LU1244550221.USD","LU1244550577.SGD","IE00B031J352.USD","LU0327786744.USD","LU1105468828.SGD","LU0620787316.HKD","00553","LU0067412154.USD","LU2264538146.SGD","LU0455707207.USD","LU0463099449.HKD","LU0516422440.USD","LU1226287529.USD","LU1960683339.HKD","LU0607220059.USD","LU0348767384.USD","01108","HK0000320264.USD","09981","LU3063872942.SGD","LU0061477393.USD","LU0210526637.USD","LU1988902786.USD","LU0163747925.USD","LU0828237940.HKD","LU1224709979.USD","LU0345780521.USD","LU0708995583.HKD","LU0287142896.SGD","LU2394011477.USD","BK1507","LU1366334651.USD","BK1533","LU0214875030.USD","02359","SG9999014674.SGD","00568","IE0032431581.USD","LU0588546209.SGD","BK1116","BK1564","LU1023057109.AUD","LU0648948544.HKD","LU0140636845.USD","HK0000306701.USD","LU0531971595.HKD","BK1193","LU0589944569.HKD","LU0384037296.USD","SG9999002828.SGD","LU0348816934.USD","LU1115378108.SGD","LU0329678170.USD","LU0561508036.HKD","LU2097828474.EUR","06826","LU1366334578.USD","LU0048580855.USD","BK1141","LU0828238088.HKD","LU1282649141.HKD","01812","LU0370786039.SGD","HK0000352291.HKD","LU0979878070.USD","LU1282649067.USD","LU1504937902.USD","03268","BK1202","LU1008478684.HKD","03986","LU0082770016.SGD","LU1961090484.USD","LU0348735423.USD","LU1880383366.USD","LU0039217434.USD","HK0000352382.USD","83188","BK1223","LU0593848301.USD","BK1560","LU1993786604.SGD","LU0029875118.USD","03308","LU0501845795.SGD","LU2242644610.SGD","BK1191","IE00BGHQDM52.EUR","IE00B0169L03.USD","LU1242518857.USD","LU1244550494.USD","LU0828237510.HKD","LU2097828631.EUR","IE0008369823.USD","03328","02827","BK1125","LU2226246903.HKD","LU0516422952.EUR","83130","03296","LU0051755006.USD","00300","IE00BYV24P56.USD","LU0531970944.HKD","BK1546","LU1794554557.SGD","BK1530","BK1149","LU0871576103.HKD","LU0886674414.USD","02338","LU0049853897.USD","LU0572944931.SGD","LU0417516902.SGD","LU0791590937.USD","399300","LU0456846285.SGD","LU0502904849.HKD","BK1594","LU1242518931.SGD","00991","01057","LU0106252389.USD","LU0266512127.USD","IE00BMCWC346.EUR","LU2177674079.SGD","BK1506","BK1521","HK0000306685.HKD","LU1046422090.SGD","LU1048596156.SGD","LU0359201885.HKD","03130","01033","LU0165289439.USD","02899","LU2097828805.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100056289","title":"Shandong Oriental Ocean Secures Regulatory Approval for Its Scavenger Receptor-A Assay Kit","url":"https://stock-news.laohu8.com/highlight/detail?id=1100056289","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100056289?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:06","pubTimestamp":1788249995,"startTime":"0","endTime":"0","summary":"Shandong Oriental Ocean Sci-Tech Co.,Ltd. (002086.SZ) announced that its wholly-owned subsidiary, Aviwe Bio-Tech Co., Ltd., has obtained the medical device registration certificate for the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","HART","IEIH","AGNG","002086","RSPH","BK0092","MDEV","BK1100","BK1574","MEDX","LGHT","09996","BK0046","PTH","GDOC","159883","BK1583","BK0213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132713513","title":"Novartis Faces Dual Outcomes: CAR-T Halted After Three Deaths While MS Drug Shows Late-Stage Promise","url":"https://stock-news.laohu8.com/highlight/detail?id=1132713513","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132713513?lang=en_us&edition=fundamental","pubTime":"2026-09-01 15:50","pubTimestamp":1788249011,"startTime":"0","endTime":"0","summary":"Swiss pharmaceutical giant Novartis AG (NVS.US) is experiencing a stark contrast in its neuro-immunology pipeline, as progress in one area is overshadowed by a serious setback in another. The company...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211331839.USD","BK4588","NVS","BK4007","PPH","BMED","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU0070302665.USD","01477","LU0208291251.USD","IE00B2B36J28.USD","MEDX","PSYK","IBBQ","BK1574","IE00B4R5TH58.HKD","IE0009355771.USD","IE0002141913.USD","IBBJ","BK4585","BK1191","MDTX","BK4532","BK4578","LU0320765489.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664887351","title":"Edding Genor Chairman to Boost Shareholding","url":"https://stock-news.laohu8.com/highlight/detail?id=2664887351","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664887351?lang=en_us&edition=fundamental","pubTime":"2026-09-01 10:38","pubTimestamp":1788230287,"startTime":"0","endTime":"0","summary":"Edding Genor Group Holdings  Chairman and CEO Ni Xin plans to spend up to $1 million to buy additional company shares, according to a Hong Kong Exchange filing on Monday.Ni will execute the open market share purchases using his personal funds.The biopharmaceutical company added that it has commenced its planned stock buyback, and the repurchased shares will be used for employee incentives, market capitalization management or other purposes, the filing said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1583","BK1574","06998","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105562547","title":"Pharmaceutical Agent Sentenced for Bribery After Profiting 1.47 Million and Returning 1.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1105562547","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105562547?lang=en_us&edition=fundamental","pubTime":"2026-09-01 10:21","pubTimestamp":1788229261,"startTime":"0","endTime":"0","summary":"A pharmaceutical sales representative has been sentenced to prison for offering kickbacks to state personnel, according to a judgment recently made public on China Judgements Online.Court documents...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1161","BK1574","159938","PRTO","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167267953","title":"MP CARDIOFLOW-B (02160) Trading Halt Scheduled From September 1st","url":"https://stock-news.laohu8.com/highlight/detail?id=1167267953","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167267953?lang=en_us&edition=fundamental","pubTime":"2026-09-01 08:58","pubTimestamp":1788224295,"startTime":"0","endTime":"0","summary":"MP CARDIOFLOW-B (02160) has announced that its shares will be suspended from trading starting at 9:00 a.m. today, September 1, 2026.The company issued an official statement confirming the temporary...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1239","02918","BK1574","02160","BK1100","BK1225","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176183367","title":"Dizal's Sunvozertinib Licensing Deal with AstraZeneca Officially Takes Effect","url":"https://stock-news.laohu8.com/highlight/detail?id=1176183367","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176183367?lang=en_us&edition=fundamental","pubTime":"2026-09-01 08:50","pubTimestamp":1788223828,"startTime":"0","endTime":"0","summary":"Dizal Pharmaceutical Co.,Ltd. (688192.SH) has announced that its exclusive licensing agreement with AstraZeneca UK Limited for the global development and commercialization of Sunvozertinib has...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1574","BK1161","BK0239","688192","BK1515","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169588395","title":"Trump Administration’s Medicaid Drug Pricing Deal Set to Stir Asian Pharma Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1169588395","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169588395?lang=en_us&edition=fundamental","pubTime":"2026-09-01 07:20","pubTimestamp":1788218431,"startTime":"0","endTime":"0","summary":"Shares of Asian pharmaceutical companies could see market movement following the Trump administration’s announcement of a new drug pricing agreement with nine biotech and pharmaceutical firms. Under...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XHS","01477","BK1574","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143660951","title":"EDDING GENOR (06998) Spends HK$619,900 on Share Buyback on August 31","url":"https://stock-news.laohu8.com/highlight/detail?id=1143660951","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143660951?lang=en_us&edition=fundamental","pubTime":"2026-09-01 06:38","pubTimestamp":1788215890,"startTime":"0","endTime":"0","summary":"EDDING GENOR (06998) announced that on August 31, 2026, the company allocated HK$619,900 to repurchase 397,500 of its own shares.This buyback activity reflects the company's ongoing capital...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1161","06998","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664882693","title":"CanSino Biologics Inc. Just Missed Earnings - But Analysts Have Updated Their Models","url":"https://stock-news.laohu8.com/highlight/detail?id=2664882693","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664882693?lang=en_us&edition=fundamental","pubTime":"2026-09-01 06:24","pubTimestamp":1788215066,"startTime":"0","endTime":"0","summary":"It's been a good week for CanSino Biologics Inc. ( HKG:6185 ) shareholders, because the company has just released its...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6185/cansino-biologics-shares/news/cansino-biologics-inc-just-missed-earnings-but-analysts-have","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6185/cansino-biologics-shares/news/cansino-biologics-inc-just-missed-earnings-but-analysts-have","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["06185","VOTE","BK1574","DECU","JOYT","VGFPF","BK1515","GXDW","BK1191","RGLO","BK1161","FEBU","PMDE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664885193","title":"Sweden's Klaria Net Loss Narrows on Lower R&D Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2664885193","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664885193?lang=en_us&edition=fundamental","pubTime":"2026-09-01 06:08","pubTimestamp":1788214086,"startTime":"0","endTime":"0","summary":"Sweden's Klaria net loss narrows on lower R&D expensesOverviewSweden pharma developer reported no Q2 net sales, unchanged from prior yearQ2 net loss after tax narrowed year-over-year, with lower R&D e","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S13U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","01672","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664159885","title":"Edding Genor Files HKEX Next-Day Disclosure Return on Share Buyback at HKD 1.56 Avg Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2664159885","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664159885?lang=en_us&edition=fundamental","pubTime":"2026-09-01 06:06","pubTimestamp":1788213976,"startTime":"0","endTime":"0","summary":"Edding Genor files HKEX next-day disclosure return on share buyback at HKD 1.56 avg priceEdding Genor filed a next-day disclosure return reporting a repurchase of 397,500 shares on Aug. 31, held as tr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL9dVTP8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1574","06998","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664881007","title":"Sinomab Bioscience Posts HY Loss of Rmb127.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2664881007","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664881007?lang=en_us&edition=fundamental","pubTime":"2026-09-01 00:52","pubTimestamp":1788195169,"startTime":"0","endTime":"0","summary":"BRIEF-Sinomab Bioscience Posts HY Loss Of RMB127.4 MillionAug 31 (Reuters)-SinoMab BioScience Ltd3681.HK:HY LOSS RMB127.4 MILLIONFurther company coverage:3681.HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0D9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","03681","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":9,"totalSize":257,"code":"91000000","status":"200"}]}}